Perlmutter Cancer Center - NYU Langone Medical Center

160 East 34th Street
New York, New York 10016

We've found

1 trials

at this facility

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Status: Enrolling, Phase II
Updated: 2/7/2018

from

New York, NY

Use our guide to learn which trials are right for you!